Validation of the prediction score for inhibitor development in previously untreated patients (PUPs) with severe hemophilia A

被引：0
|
作者：
Hashemi, S. [1 ,2 ,3 ]
Fischer, K. [1 ,2 ]
Van den Berg, H. [3 ]
机构：
[1] UMC Utrecht, Dept Creveldklin & Hematol, Utrecht, Netherlands
[2] UMC Utrecht, Julius Ctr Hlth Sci, Utrecht, Netherlands
[3] UMC Utrecht, Dept Clin Chem & Haematol, Utrecht, Netherlands
来源：
HAEMOPHILIA | 2012年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
下载
收藏
页码：89 / 89
页数：1
相关论文
共 50 条
  • [1] Inhibitor incidence in previously untreated patients (PUPs) with severe hemophilia A receiving recombinant factor (rFVIII)
    Rothschild, C
    Laurian, Y
    Satre, EP
    BorelDerlon, A
    Chambost, H
    Moreau, P
    Goudemand, J
    Parquet, A
    Vicariot, M
    Beurrier, P
    Claeyssens, S
    Durin, A
    Faradji, A
    Fressinaud, E
    Gaillard, S
    Guerin, V
    Guerois, C
    Pernod, G
    Peynet, J
    Pouzol, P
    Schved, JF
    Gazengel, C
    THROMBOSIS AND HAEMOSTASIS, 1997, : P2654 - P2654
  • [2] Risk of bleeding and inhibitor development after circumcision of Previously Untreated (PUPs) or Minimally Treated (MTPs) severe hemophilia A patients
    Elalfy, M.
    Elbarbary, N.
    Eldebeiky, M.
    El Danasoury, A.
    HAEMOPHILIA, 2012, 18 : 89 - 89
  • [3] Transcriptomic Profiling to Understand Inhibitor Development in Previously Untreated Patients with Severe Hemophilia a
    Batty, Paul
    Watson, David
    Wozniak, Eva
    Mein, Charles
    Barnes, Michael
    BLOOD, 2023, 142
  • [4] Low inhibitor incidence in previously untreated hemophilia A patients (PUPs) treated with Octanate®
    Klukowska, A.
    Laguna, P.
    Komrska, V.
    Jansen, M.
    HAEMOPHILIA, 2010, 16 : 37 - 37
  • [5] Improved prediction of inhibitor development in previously untreated patients with severe haemophilia A
    Hashemi, S. M.
    Fischer, K.
    Moons, K. G. M.
    van den Berg, H. M.
    HAEMOPHILIA, 2015, 21 (02) : 227 - 233
  • [6] Tailoring hemostatic therapies to lower inhibitor development in previously untreated patients with severe hemophilia A
    Mannucci, P. M.
    Mancuso, M. E.
    Franchini, M.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2016, 14 (07) : 1330 - 1336
  • [7] Timing of inhibitor development in more than 1000 previously untreated patients with severe hemophilia A
    van den Berg, H. Marijke
    Fischer, Kathelijn
    Carcao, Manuel
    Chambost, Herve
    Kenet, Gili
    Kurnik, Karin
    Konigs, Chris
    Male, Christoph
    Santagostino, Elena
    Ljung, Rolf
    BLOOD, 2019, 134 (03) : 317 - 320
  • [8] Inhibitor development in previously untreated patients (PUPs) with hemophilia A and B: A prospective 23-year-follow-up
    Ettingshausen, CE
    Zyschka, A
    Oldenburg, J
    Saguer, IM
    Ehrenforth, S
    Kreuz, W
    Goethe, JW
    THROMBOSIS AND HAEMOSTASIS, 1999, : 410 - 410
  • [9] A safety and efficacy evaluation of rFIX in previously untreated patients (PUPS) with severe and moderately severe hemophilia B
    Shapiro, A
    Pasi, KJ
    Courter, S
    Tubridy, K
    THROMBOSIS AND HAEMOSTASIS, 1997, : PS212 - PS212
  • [10] Factor VIII prophylaxis and inhibitor development in previously untreated patients with severe hemophilia A: the RODIN study
    Gouw, S. C.
    Van den Berg, M.
    Auerswald, G.
    Carcao, M.
    Chalmers, E.
    Chambost, H.
    Fischer, K.
    Kurnik, K.
    Liesner, R.
    Petrini, P.
    Platokouki, H.
    Altisent, C.
    Oldenburg, J.
    Nolan, B.
    Perez Garido, R.
    Rafowicz, A.
    Williams, M.
    Van der Bom, J. G.
    HAEMOPHILIA, 2012, 18 : 3 - 4
12345